Stalk us here
Powered by Fresh Ideas

Innovation Spurs Growth for Campari, Coca-Cola, and AG Barr

Source: www.beveragedaily.com
73 EN 中文 DE FR عربى
Campari, Coca-Cola Europacific Partners, and AG Barr have reported growth driven by innovation despite market challenges. Campari saw a slight decrease in net sales but noted innovation as a key differentiator. Coca-Cola Europacific Partners reported a 6.1% revenue increase, while AG Barr faced distribution issues but saw strong brand performance.
Innovation Spurs Growth for Campari, Coca-Cola, and AG Barr

Campari Group, the Italian drinks giant, emphasized the importance of innovation as a 'critical differentiator' amid challenging market conditions in its financial results for the first six months of 2026. Despite a 1% decrease in organic net sales to €1.5 billion compared to the same period in 2025, Campari achieved an organic growth of 2.7%. The company reported a gross profit increase of 1.3%, amounting to €946 million. Campari noted that changing consumer habits, such as Gen Z's focus on moderation and health, along with inflation and weaker real incomes, are reshaping consumption patterns.

Coca-Cola Europacific Partners (CCEP) experienced a 6.1% increase in revenue and an 8.1% rise in operating profit for the first half of 2026. The growth was attributed to new product variants and promotional activities related to the FIFA World Cup. Damian Gammell, CEO of CCEP, highlighted the company's focus on beverage innovation and expansion in markets like the Philippines and Indonesia. Products like Coke Zero Sugar saw a 10.7% increase, and new flavors such as Cherry Float contributed to the performance.

AG Barr, a UK-based beverage company, also reported growth driven by innovation, despite facing a £10 million impact on its balance sheet due to distribution issues. The company expects revenue for the first half of the year to reach approximately £246 million, an 8% increase from the previous year. AG Barr's CEO, Euan Sutherland, mentioned the integration of Frobishers and Fentimans and ongoing manufacturing investments as key factors in their strategy. He also expressed confidence in resolving supply constraints and achieving full-year growth.